Yuan, R., Cheng, Z., & Zhan, X. (2025). TRIB3 is a biomarker of poor prognosis in laryngeal squamous cell carcinoma and may affect tumor development through PI3K / AKT / mTOR pathway.
Citación estilo ChicagoYuan, Runsheng, Zhongqiang Cheng, y Xiaodong Zhan. TRIB3 Is a Biomarker of Poor Prognosis in Laryngeal Squamous Cell Carcinoma and May Affect Tumor Development Through PI3K / AKT / MTOR Pathway. 2025.
Cita MLAYuan, Runsheng, Zhongqiang Cheng, y Xiaodong Zhan. TRIB3 Is a Biomarker of Poor Prognosis in Laryngeal Squamous Cell Carcinoma and May Affect Tumor Development Through PI3K / AKT / MTOR Pathway. 2025.
Precaución: Estas citas no son 100% exactas.